Connection

Wim Van Damme to Immunogenicity, Vaccine

Back to Details
This is a "connection" page, showing publications Wim Van Damme has written about Immunogenicity, Vaccine.
Wim Van Damme
Connection Strength
0.073
Immunogenicity, Vaccine
  1. Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine. N Engl J Med. 2021 05 13; 384(19):1824-1835.
    View in: PubMed
    Score: 0.073
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.